Complexes with biologically active ligands. Part 8 synthesis and carbonic anhydrase inhibitory activity of 5-benzoylamido- and 5-(3-nitrobenzoylamido)-1,3,4-thiadiazole-2-sulfonamide and their metal complexes

Main Group Metal Chemistry

Volumn 20, Issue 3, 1997, Pages 151-156

  Jitianu, Andrei ^a   Hies, Marc A ^a   Scozzafava, Andrea ^b   Supuran, Claudiu T ^b  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 19644378927     PISSN: 07921241     EISSN: 21910219     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. D. Hewett-Emmett, R.E. Tashian, Mol.Phylogenet.Evol., 1996, 5, 50-77.
2. a) T.H. Maren, Pharmacol.Rev., 1967, 47, 595-782;
3. b) T.H. Maren, J. Glaucoma, 1995, 4, 49-62.
4. a) C.T. Supuran, "Carbonic anhydrase inhibitors", in "Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism", I. Puscas Ed., Helicon, Timisoara 1994, pp. 29-111;
5. b) I. Puscas, C.T. Supuran, "Farmacologia clinica da ulcera peptica" in "Aparelho Digestivo", J. Coelho Ed., MEDSI, Rio de Janeiro, 1996, pp. 1704-1734.
6. I. Puscas, C.T. Supuran, ". Carbonic anhydrase is an important physiological modulator. The pH theory", in "Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism", I. Puscas Ed., Helicon, Timisoara 1994, pp. 146-175.
7. D.M. Woodbury, "Carbonic anhydrase inhibitors" in "Antiepileptic Drugs: Mechanisms of Action", G.H. Glaser, J.K. Penry and D.M. Woodbury Eds., Raven, New York, 1980, pp. 617-633.
8. T.J. Hall, M. Schaueblin, Calcif.Tissue Int., 1994, 55, 266-268.
9. B.A. Teicher, S.D. Liu, J.T. Liu, S.A. Holden, T.S. Herman, Anticancer Res., 1993, 13, 1549-1556.
10. I. Puscas, M. Coltau, D. Farcau, C. Puscas, C.T. Supuran, "Carbonic anhydrase and cancer", in "Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism", I. Puscas Ed., Helicon, Timisoara 1994, pp. 551-558.
11. J. Pastorek, S. Pastorekova, I. Callebaut, J.P. Mornon, V. Zelnik, R. Opavsky, M. Zatovicova, S. Liao, D. Portetelle, E.J. Stanbridge, Oncogene, 1994, 9, 2877-2888.
12. a) C.T. Supuran, B.W. Clare, Eur.J.Med.Chem., 1995, 30 687-696;
13. b) C.T. Supuran, A. Nicolae, A. Popescu, Eur.J. Med.Chem., 1996, 31, 431-438;
14. c) C.T. Supuran, A. Popescu, M. Ilisiu, A. Costandache, M.D. Banciu, Eur.J.Med.Chem., 1996, 31, 439-447;
15. d) C.T. Supuran, C.W. Conroy, T.H. Maren, Eur.J.Med.Chem., 1996, 31, 843-846;
16. e) F. Briganti, R. Pierattelli, A. Scozzafava, C.T. Supuran, Eur.J.Med.Chem., 1996, 31, (in press).
17. a) M. Rivière-Baudet, C.T. Supuran, Main Group Met. Chem., 1996, 19, 579-584;
18. b) A. Scozzafava, F. Briganti, C.T. Supuran, I. Fenesan, R. Popescu, V. Muresan, S. Farcas, Main Group Met. Chem., 1996, 19, 503-507;
19. c) C.T. Supuran, M.D. Banciu, G. Botez and A.T. Balaban, Rev.Roum.Chim., 1992, 37, 1375-1383;
20. d) C.T. Supuran, I. Saramet and M.D. Banciu, Rev.Roum.Chim., 1995, 40, 1227-1232;
21. e) C.T. Supuran, V. Muresan, R. Popescu and I. Fenesan, Main Group Met. Chem., 1995, 18, 629-632;
22. f) C.T. Supuran, S.V. Serves and P.V. Ioannou, J.Inorg.Biochem., 1996, 62, 207-213.
23. a) G. Alzuet, S. Ferrer, J. Borras, C.T. Supuran, Roum.Chem.Quart.Rev., 1994, 2, 283-300;
24. b) C.T. Supuran, R. Stefan, G. Manole, I. Puscas, M. Andruh, Rev.Roum.Chim., 1991, 36, 1175-1179;
25. c) C.T. Supuran, G. Manole, M. Andruh, J.Inorg.Biochem., 1993, 49, 97-103;
26. d) C.T. Supuran, Rev.Roum. Chim., 1992, 37, 849-855
27. a) C.T. Supuran, Rev.Roum.Chim., 1993, 38, 229-236;
28. b) C.T. Supuran, Roum.Chem.Quart.Rev., 1993, 1, 77-116;
29. c) S.L. Sumalan, J. Casanova, G. Alzuet, J. Borras, A. Castiñeiras, C.T. Supuran, J.Inorg.Biochem., 1996, 62, 31-39;
30. d) C.T. Supuran, G.L. Almajan, Main Group Met. Chem., 1995, 18, 347-351;
31. e) C.T. Supuran, Metal Based Drugs, 1995, 2, 327-330;
32. f) C.T. Supuran, Metal Based Drugs, 1995, 2, 331-336;
33. g) J. Borras, T. Cristea, C.T. Supuran, Main Group Met. Chem., 1996, 19, 339-346;
34. h) J. Borras, J Casanova, T. Cristea, A. Gheorghe, A. Scozzafava, C.T. Supuran, V. Tudor, Metal Based Drugs, 1996, 3, 143-148.
35. P. Borja, J. Casanova, G. Alzuet, J. Borras, C.T. Supuran, manuscript in preparation.
36. a) C. Forsman, G. Behravan, A. Osterman and B.H. Jonsson, Acta Chem. Scand., 1988, B42, 314-318;
37. b) G. Behravan, P. Jonasson, B.H. Jonsson and S. Lindskog, Eur.J.Biochem., 1991, 198, 589-592.
38. R.G. Khalifah, D.J. Strader, S.H. Bryant and S.M. Gibson, Biochemistry, 1977, 16, 2241-2247.
39. a) P.O. Nyman and S. Lindskog, Biochim.Biophys.Acta, 1964, 55, 141-151;
40. b) L.E. Henderson, D. Henriksson and P.O. Nyman, J.Biol.Chem., 1976, 251, 5457-5463.
41. T.H. Maren, C.W. Conroy and P.J. Wistrand, Mol. Pharmacol., 1993, 44, 901-906.
42. Y. Pocker and J.T. Stone, Biochemistry, 1967, 6, 668-679.
43. D. Le Bar, S.K. Luthra, V.W. Pike, E.R. Swenson, Appl.Radiat.Isot., 1988, 39, 671-675.
44. W.S. Sly, S. Sato, X.L. Zhu, Clin. Biochem., 1991, 24, 311-318.